Research
The GLP-1 Bridge Nobody Wanted to Underwrite: Why Medicare's $50 Copay Is a Fiscal Event, Not a Pharma One
Medicare will cover GLP-1s for obesity from July 1. Private insurers refused the BALANCE risk and CMS took it on alone. The biotechs got the easy read. The fiscal arithmetic is the harder one.